Make your money go further for just 25p per day

Tristel (AIM: TSTL) – cracking results and positive outlook bring out more upgrades

12/10/2015 · Tristel (TSTL) 

The AIM quoted manufacturer of infection prevention and contamination control products, announces excellent ‘audited’ results for the year ahead of expectations with a resulting upgrade from the house broker. 

The Group’s proprietary chlorine dioxide formulation and the Company addresses three distinct markets:

- The Human Healthcare market (hospital infection prevention - via the Tristel brand) represents 85% of Group sales
- The Contamination Control market (control of contamination in critical environments - via the Crystel brand)
- The Animal Healthcare market (veterinary practice infection prevention - via the Anistel brand)

Tristel’s proprietary chlorine dioxide chemistry has two defining features: first, it kills bacterial spores very quickly; second, it is safe to use.  As a consequence, Tristel’s surface disinfectants provide the most effective stratagem to control Clostridium difficile, one of the most problematic pathogens in hospitals. 

For the year ending 30th June 2015 turnover was up 14% to £15.3m, pre-tax profit up 44% to £2.6m and basic earnings per share up a whopping 67% to 5.44p. The full year dividend per share was increased to 5.72p (2014: 1.62p) and included a special…

Sign up and read the full article

Register to continue reading this article.

Get FREE access now

Already a member? Login

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world


Become a Champion Investor for as little as £3.20 per report or get a year's worth of money-making analysis for just £90.


More on Tristel

Portfolio Flash News: April

30/04/2019 · Portfolio Flash News

It’s not always easy to keep track of your investments. Sometimes big news gets hidden in…

Investor’s Champion podcast: ISA time

03/04/2019 · Podcasts
It’s ISA time. With just two days to go before the ISA deadline, it’s a good…

Tristel gains key approval in China

01/04/2019 · Portfolio Flash News
Tristel has its sights firmly set on China as a crucial market for long-term revenue growth.…

Tristel looks to China for more growth

13/03/2019 · Portfolio

The value of Tristel’s medical device decontamination products are highlighted by the fact that the company…

6 quality AIM shares for your portfolio

15/10/2015 · News & Insights
Our Blog this week has featured results and updates from a number of wonderful small…

More from the News & Insights

Sports Direct struggles to manage Goals

Premier Technical Services 140% premium - who missed out?

Video games developer Team17 continues to impress

18/06/2019 · Team17 Group PLC